Suicidal Ideation Trajectories After Alerts: A retrospective cohort using Digital Measurement-Based Care for Mood Disorders (Preprint)
Authors:
- Antoine YrondiAYAntoine Yrondi
- Anne SauvagetASAnne Sauvaget
- Florian StephanFSFlorian Stephan
- Samuel BulteauSBSamuel Bulteau
- Styliani DolianitiSDStyliani Dolianiti
- Christophe DaudetCDChristophe Daudet
- Wissam El-HageWissam El-Hage
- Hadj AmraniHAHadj Amrani
- Nathalie LeleNLNathalie Lele
- Ionela BotaIBIonela Bota
- Jacques NartowskiJNJacques Nartowski
- Corinne MarieCMCorinne Marie
Preprint
- 8 July 2026
- preprint
- Published by JMIR Publications Inc. in JMIR Preprints
Abstract
BACKGROUND Measurement-based care improves depression outcomes, yet implementation remains uncommon. Digital remote patient monitoring (RPM) tools collecting patient-reported outcomes (PROs) with automated alerts are increasingly deployed, but the respective contributions of algorithmic detection and clinician response remain unclear. OBJECTIVE To describe real-world use of a CE-marked digital RPM device for mood disorders and characterize symptom trajectories around algorithmic alerts, distinguishing alerts overall from those followed by clinician response. METHODS Multicenter retrospective cohort study using post-market clinical follow-up data from October 31, 2025, to May 4, 2026, implying thirty-four French psychiatric centers using a Class IIa CE-marked RPM device. We included all consecutive adults (≥18 years) treated for major depressive episode or manic episode, who completed at least one weekly questionnaire and did not opt out of research use of their data. The questionnaires consisted in weekly electronic PROs collection (PHQ-9, suicidal ideation item, adapted GAD-2, medication adherence) with threshold-based alerts routed to clinical teams. Alerts were classified as followed or not by documented clinician response. Outcomes included engagement and operational metrics (completion rate, patient response time, alert processing time, response conversion rate) and exploratory pre/post-alert trajectories for suicidal ideation, anxiety, and depression, analyzed using segmented interrupted time-series regression with Newey-West correction at both the alert and response-bearing alert levels. RESULTS Among 111 patients (median [IQR] age, 41 [31-54] years; 76% female), 84% were treated for depressive disorders, and 16% for bipolar disorder. Overall, 92% of questionnaires were completed, with completion rates exceeding 80% through month 5. Median patient response time was 17 hours, median clinician response time after alerts was 50 hours, and 69% of alerts were followed by a documented response. Response-bearing alerts were associated with significant slope inflections for suicidal ideation (−0.007/day; P=0.01) and anxiety (−0.004 per day; P<0.001), with nonsignificant trend for depression. Across all alerts, no inflection was observed for suicidal ideation, whereas anxiety showed a significant inflection and depression a level shift without slope change. CONCLUSIONS In this real-world cohort, symptom trajectory changes were most evident when alerts were followed by clinician response. These findings support further evaluation of closed-loop RPM in randomized trials. CLINICALTRIAL The study was conducted under the French Reference Methodology MR-004 of the Commission Nationale de l'Informatique et des Libertés (CNIL) (research not involving human subjects, in-house studies on health data).Keywords
This publication has 22 references indexed in Scilit:
- Measurement-Based Care to Enhance Antidepressant Treatment Outcomes in Major Depressive DisorderJAMA Network Open, 2025
- Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019The Lancet Psychiatry, 2022
- The efficacy of app‐supported smartphone interventions for mental health problems: a meta‐analysis of randomized controlled trialsWorld Psychiatry, 2019
- The effect of smartphone-based monitoring on illness activity in bipolar disorder: the MONARCA II randomized controlled single-blinded trialPsychological Medicine, 2019
- Implementing Measurement-Based Care in Behavioral HealthJAMA Psychiatry, 2019
- Adherence and Persistence Across Antidepressant Therapeutic Classes: A Retrospective Claims Analysis Among Insured US Patients with Major Depressive Disorder (MDD)CNS Drugs, 2017
- Effectiveness of an integrated telehealth service for patients with depression: a pragmatic randomised controlled trial of a complex interventionThe Lancet Psychiatry, 2016
- CLINICAL OUTCOMES IN MEASUREMENT-BASED TREATMENT (COMET): A TRIAL OF DEPRESSION MONITORING AND FEEDBACK TO PRIMARY CARE PHYSICIANSDepression and Anxiety, 2012
- A Brief Measure for Assessing Generalized Anxiety DisorderArchives of internal medicine (1960), 2006
- The Altman Self-Rating Mania ScaleBiological Psychiatry, 1997